| # | Drug | Count |
|---|---|---|
| 0 | RYDAPT | 3 |
| 1 | AZACITIDINE | 2 |
| 2 | BISOPROLOL FUMARATE | 2 |
| 3 | CETIIRIZINE | 2 |
| 4 | CETIRIZINE | 2 |
| 5 | CETIRIZINE HYDROCHLORIDE | 2 |
| 6 | AXICABTAGENE CILOLEUCEL | 1 |
| 7 | BEVACIZUMAB | 1 |
| 8 | CARBOPLATIN | 1 |
| 9 | CLADRIBINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RYDAPT | 3 | 0.0015 |
| 1 | CLADRIBINE | 1 | 0.0001 |
| 2 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 3 | RANOLAZINE | 1 | 0.0001 |
| 4 | TOLVAPTAN | 1 | 0.0001 |
| 5 | AZACITIDINE | 2 | 0.0001 |
| 6 | CETIIRIZINE | 2 | 0.0000 |
| 7 | IMATINIB MESYLATE | 1 | 0.0000 |
| 8 | NILOTINIB | 1 | 0.0000 |
| 9 | HYDROXYZINE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 1 | Anti-anginal [EPC] | 1 | 0.0001 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Histamine-1 Receptor Antagonist [EPC] | 2 | 0.0000 |
| 4 | Kinase Inhibitor [EPC] | 8 | 0.0000 |
| 5 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 1 | 0.0000 |